165 related articles for article (PubMed ID: 36867344)
21. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
Jin S; Li X; Dai Y; Li C; Wang D
Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
[TBL] [Abstract][Full Text] [Related]
22. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
23. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
Holland EC; Hively WP; DePinho RA; Varmus HE
Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
[TBL] [Abstract][Full Text] [Related]
24. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.
Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW
J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776
[TBL] [Abstract][Full Text] [Related]
25. Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma.
Breunig JJ; Levy R; Antonuk CD; Molina J; Dutra-Clarke M; Park H; Akhtar AA; Kim GB; Hu X; Bannykh SI; Verhaak RG; Danielpour M
Cell Rep; 2015 Jul; 12(2):258-71. PubMed ID: 26146073
[TBL] [Abstract][Full Text] [Related]
26. TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.
Chen C; Han S; Meng L; Li Z; Zhang X; Wu A
PLoS One; 2014; 9(6):e100297. PubMed ID: 24937153
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
[TBL] [Abstract][Full Text] [Related]
28. Gliomagenesis and the use of neural stem cells in brain tumor treatment.
Achanta P; Sedora Roman NI; Quiñones-Hinojosa A
Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546
[TBL] [Abstract][Full Text] [Related]
29. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
[TBL] [Abstract][Full Text] [Related]
30. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
[TBL] [Abstract][Full Text] [Related]
31. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
32. H3.3
Pathania M; De Jay N; Maestro N; Harutyunyan AS; Nitarska J; Pahlavan P; Henderson S; Mikael LG; Richard-Londt A; Zhang Y; Costa JR; Hébert S; Khazaei S; Ibrahim NS; Herrero J; Riccio A; Albrecht S; Ketteler R; Brandner S; Kleinman CL; Jabado N; Salomoni P
Cancer Cell; 2017 Nov; 32(5):684-700.e9. PubMed ID: 29107533
[TBL] [Abstract][Full Text] [Related]
33. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.
Caulin C; Nguyen T; Lang GA; Goepfert TM; Brinkley BR; Cai WW; Lozano G; Roop DR
J Clin Invest; 2007 Jul; 117(7):1893-901. PubMed ID: 17607363
[TBL] [Abstract][Full Text] [Related]
34. Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.
Clément-Schatlo V; Marino D; Burkhardt K; Teta P; Leyvraz F; Schatlo B; Frank S; Schaller K; Castella V; Radovanovic I
Neuro Oncol; 2012 Jun; 14(6):720-35. PubMed ID: 22584872
[TBL] [Abstract][Full Text] [Related]
35. CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma.
Xiaoping L; Zhibin Y; Wenjuan L; Zeyou W; Gang X; Zhaohui L; Ying Z; Minghua W; Guiyuan L
Cell Death Dis; 2013 Jun; 4(6):e675. PubMed ID: 23788032
[TBL] [Abstract][Full Text] [Related]
36. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
37. Molecular Characteristics of Thalamic Gliomas in Adults.
Wang T; Niu X; Gao T; Zheng L; Qiu Y; Mao Q
J Mol Neurosci; 2021 Aug; 71(8):1598-1604. PubMed ID: 33523385
[TBL] [Abstract][Full Text] [Related]
38. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
39. A drosophila model for EGFR-Ras and PI3K-dependent human glioma.
Read RD; Cavenee WK; Furnari FB; Thomas JB
PLoS Genet; 2009 Feb; 5(2):e1000374. PubMed ID: 19214224
[TBL] [Abstract][Full Text] [Related]
40. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
